Branded

Merck to acquire OncoImmune, potential COVID-19 treatment
Merck will acquire Oncolmmune, which recently announced positive findings from a Phase 3 study of its candidate for the treatment of patients with severe and critical COVID-19.
FDA grants emergency use authorization for Lilly’s baricitinib as combination COVID-19 treatment
Eli Lilly and Incyte have received emergency use authorization from the Food and Drug Administration for baricitinib in combination with remdesivir in hospitalized adult and pediatric patients age 2 years old or older with COVID-19.

FDA approves expanded indications for UCB’s Vimpat

UCB’s Vimpat has received the Food and Drug Administration’s nod for primary generalized tonic-clonic seizures, as well as expanded pediatric use for people with epilepsy.
Eli Lilly’s bamlanivimab earns Emergency Use Authorization to treat COVID-19

Eli Lilly's bamlanivimab has received the Food and Drug Administration’s nod for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.
FDA OKs new indication for AstraZeneca’s Brilinta

AstraZeneca’s Brilinta (ticagrelor) is now approved to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-risk transient ischemic attack.
Kala Pharmaceuticals gets FDA OK for Eysuvis

Kala Pharmaceuticals' Eysuvis provides a short-term treatment of the signs and symptoms for dry eye disease.
Sanofi inks deal to acquire Kiadis

Sanofi has agreed to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products.
Boehringer Ingelheim names Yew Looi Liew president of U.S. human pharma

Yew Looi Liew succeeds Jean-Michel Boers as president of Boehringer Ingelheim's U.S. human pharma.
Gilead’s Veklury becomes first treatment approved for COVID-19

Gilead Sciences' Veklury has been approved to treat hospitalized patients with COVID-19 who are 12 years old and older.
DOJ, Purdue come to $8B agreement that includes dissolving company

The DOJ's settlement agreement will pave the way for Purdue to submit a plan of reorganization to the bankruptcy court that will transfer all of Purdue’s assets to a public benefit company.

Merck to acquire OncoImmune, potential COVID-19 treatment

FDA grants emergency use authorization for Lilly’s baricitinib as combination COVID-19 treatment

FDA approves expanded indications for UCB’s Vimpat

Eli Lilly’s bamlanivimab earns Emergency Use Authorization to treat COVID-19

FDA OKs new indication for AstraZeneca’s Brilinta

Kala Pharmaceuticals gets FDA OK for Eysuvis

Sanofi inks deal to acquire Kiadis

Boehringer Ingelheim names Yew Looi Liew president of U.S. human pharma

Gilead’s Veklury becomes first treatment approved for COVID-19

DOJ, Purdue come to $8B agreement that includes dissolving company